cyclophosphamide - Generic mfg.
fludarabine IV - Generic mfg.
CD22-CAR T-cell therapy - Stanford University
https://eventpilot.us/web/page.php?page=Session&project=ASH21&id=152145
 
Matthew J. Frank, MD, PhD1,2; John H. Baird, MD1,2; Shabnum Patel, PhD3; Juliana Craig, BA1,2; Jay Y. Spiegel, MD, FRCPC1,2; Zachary Ehlinger, MS3; Harshini Chinnasamy, MS2; Sheren F. Younes, MD, PhD4; Jean S. Oak, MD, PhD5; Yasodha Natkunam, MD, PhD4; Warren D. Reynolds, BS3; Maria Iglesias, BS1,2; Emma Crawford, BS2,6; Hrishikesh K. Srinagesh, MD1; Emily L. Egeler, PhD2; Sally Arai, MD, MS1; Laura J. Johnston, MD1; Robert Lowsky, MD1; Robert S. Negrin, MD1; Andrew R. Rezvani, MD1; Parveen Shiraz, MD7; Surbhi Sidana, MD1,2; Wen-Kai Weng, MD, PhD1; Liora M. Schultz, MD8; Sneha Ramakrishna, MD8; Kara L. Davis, DO9; Bita Sahaf, PhD2; Steven A. Feldman, PhD2; Crystal L. Mackall, MD2,10; David B. Miklos, MD, PhD1,2; Lori Muffly, MD2,11
 
Nov 5, 2021
 
Prev